INTS · Intensity Therapeutics, Inc.
$3.96
-0.04 (-1.00%)
At close · Aug 14
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our balances in cash and cash equivalents, our ability to continue our operations is dependent on obtaining additional capital, which is not within our control. As a result, we believe there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$12.93M
Shares
3.26M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-06-16 | — | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-30 | — | |
| 8-K | 2026-03-27 | — | |
| 10-K | 2026-03-27 | 2025-12-31 | |
| 8-K | 2026-03-23 | — | |
| 8-K | 2026-03-06 | 2026-03-05 | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2026-02-13 | — | |
| 8-K | 2025-12-05 | 2025-12-04 | |
| 8-K | 2025-12-04 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-31 | 2025-10-30 | |
| 8-K | 2025-10-23 | 2025-10-22 | |
| 8-K | 2025-09-10 | — | |
| DEF 14A | 2025-09-09 | — | |
| 8-K | 2025-08-12 | 2025-08-08 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-07-18 | 2025-07-17 | |
| 8-K | 2025-06-13 | 2025-06-11 | |
| 8-K | 2025-06-06 | — | |
| DEF 14A | 2025-06-02 | — | |
| 8-K | 2025-05-20 | 2025-05-19 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-04-25 | 2025-04-24 | |
| 8-K | 2025-04-23 | 2025-04-22 | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2025-03-13 | — | |
| 8-K | 2024-11-22 | 2024-11-21 | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-10-23 | 2024-10-21 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-17 | — | |
| 8-K | 2024-07-03 | — | |
| DEF 14A | 2024-06-04 | — | |
| 8-K | 2024-05-24 | 2024-05-21 | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 8-K | 2024-05-10 | 2024-05-06 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-04-19 | 2024-04-18 |
Showing 1–50 of 63 filings
Key facts
CIK
1567264
CUSIP
45828J202
13F (30d)
15 filings
15 filers
Visit website
Investor relations